Allurion Technologies Inc (ALUR)
0.3778
+0.03
(+10.15%)
USD |
NYSE |
Nov 18, 16:00
0.399
+0.02
(+5.61%)
After-Hours: 20:00
Allurion Technologies Enterprise Value: 29.55M for Nov. 15, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 15, 2024 | 29.55M |
| November 14, 2024 | 33.23M |
| November 13, 2024 | 41.17M |
| November 12, 2024 | 53.23M |
| November 11, 2024 | 54.10M |
| November 08, 2024 | 55.03M |
| November 07, 2024 | 52.81M |
| November 06, 2024 | 55.17M |
| November 05, 2024 | 52.90M |
| November 04, 2024 | 52.07M |
| November 01, 2024 | 53.14M |
| October 31, 2024 | 53.39M |
| October 30, 2024 | 54.50M |
| October 29, 2024 | 57.04M |
| October 28, 2024 | 56.05M |
| October 25, 2024 | 56.44M |
| October 24, 2024 | 53.78M |
| October 23, 2024 | 53.40M |
| October 22, 2024 | 55.22M |
| October 21, 2024 | 52.76M |
| October 18, 2024 | 52.82M |
| October 17, 2024 | 52.82M |
| October 16, 2024 | 56.88M |
| October 15, 2024 | 52.12M |
| October 14, 2024 | 51.27M |
| Date | Value |
|---|---|
| October 11, 2024 | 51.86M |
| October 10, 2024 | 52.82M |
| October 09, 2024 | 52.19M |
| October 08, 2024 | 53.05M |
| October 07, 2024 | 52.82M |
| October 04, 2024 | 52.82M |
| October 03, 2024 | 52.05M |
| October 02, 2024 | 51.85M |
| October 01, 2024 | 45.09M |
| September 30, 2024 | 46.89M |
| September 27, 2024 | 61.96M |
| September 26, 2024 | 63.06M |
| September 25, 2024 | 63.49M |
| September 24, 2024 | 63.53M |
| September 23, 2024 | 61.95M |
| September 20, 2024 | 61.81M |
| September 19, 2024 | 62.23M |
| September 18, 2024 | 62.92M |
| September 17, 2024 | 59.66M |
| September 16, 2024 | 58.27M |
| September 13, 2024 | 61.27M |
| September 12, 2024 | 62.23M |
| September 11, 2024 | 61.59M |
| September 10, 2024 | 63.58M |
| September 09, 2024 | 65.37M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
29.55M
Minimum
Nov 15 2024
464.01M
Maximum
Aug 02 2023
140.08M
Average
122.32M
Median
Apr 16 2024
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 240.17M |
| Retractable Technologies Inc | -21.87M |
| InfuSystems Holdings Inc | 211.74M |
| Xtant Medical Holdings Inc | 87.60M |
| Catheter Precision Inc | 1.952M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -9.004M |
| Revenue (Quarterly) | 5.367M |
| Total Expenses (Quarterly) | 17.71M |
| EPS Diluted (Quarterly) | -0.14 |
| Gross Profit Margin (Quarterly) | 57.97% |
| Profit Margin (Quarterly) | -167.8% |
| Earnings Yield | -127.1% |
| Normalized Earnings Yield | -253.28 |